ADOBE Reader is needed to view the PDF file. To download ADOBE Reader, click on the get ADOBE Reader icon.
Lexiscan (regadenoson) injection is a prescription drug given through an IV line that increases blood flow through the arteries of the heart during a cardiac nuclear stress test. Lexiscan is given to patients when they are unable to exercise adequately for a stress test.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Lexiscan is a registered trademark of Astellas US LLC. All other trademarks or registered trademarks are the property of their respective owners.
Lexiscan was developed in collaboration with Gilead Palo Alto, Inc. (formerly CV Therapeutics, Inc.).
© 2018 Astellas Pharma US, Inc. All rights reserved. 012-1310-PM 6/18